Generex Biotechnology Corporation

(NASDAQ:GNBT)

Key Stats & Ratios

Valuation
Market Cap 44.56M
P/E
P/E (Trailing)
P/E (Forward)
Price/Sales
Price/Book 2.42
EPS -0.36
EPS Growth (ttm)
Fiscal Year
Fiscal Year Ends Jul 31
Last Quarter Apr 2008
Profitability
Operating Income -33263755.00
Net Income -40704262.00
Profit Margin (ttm)
Operating Margin (ttm) -53.77%
Management Effectiveness
Return on Assets (ttm) -136.40%
Return on Equity (ttm)
EBIT Margin (ttm)
SEC Filings
Latest Form 10-Q (Quartely)
Latest Form 10-K (Annual)

Financials

Income Statement
Total Enterprise Value 37.56M
Revenue 618.52K
Revenue/Share
Revenue Growth (ytd) 1104.00%
Annual Revenue Growth Rate (3Y) -6.42%
Annual Income Growth Rate (3Y)
Earnings Growth (ytd)
Gross Operating Profit (ttm) 9.41M
EBITDA -24416867.00
Diluted EPS (ttm) -0.36
Balance Sheet
Total Cash 8.66M
Total Cash/Share 0.07
Total Assets 29.83M
Total Liabilities 14.32M
Total Debt/Equity
Long Term Debt Common Equity Ratio 0.09
Current Ratio 1.00
Leverage Ratio 1.00
Book Value/Share 0.13
Cash Flow
Cash Flow -31857374.00
Free Cash Flow -7654362.00
Cash Flow/Share -0.26
Free Cash Flow/Share -0.06

Trading Information

Stock Price History
Beta 0.43
52Wk Change -78.50%
52Wk Change Vs. Mkt -67.00%
52Wk High 1.64
52Wk Low 0.26
10 Day Moving Average 0.35
200 Day Moving Average 0.72
Share Statistics
Average Volume 763.60K
Shares Outstanding 123.77M
Shares Float 122.11M
% Held by Insiders 1.40%
% Held by Institutions 3.10%
Shares Short (As of Dec 10, 2008) 2.23M
Short Ratio 2.40
Short % of Float 1.80%
Dividends & Splits
Dividend Date
Dividend Yield
Dividend Amount